Literature DB >> 12124729

Exclusion of PITX2 mutations as a major cause of CHARGE association.

Donna M Martin1, Frank J Probst, Sharon E Fox, Lisa A Schimmenti, Elena V Semina, Margaret A Hefner, John W Belmont, Sally A Camper.   

Abstract

CHARGE is a nonrandom association of ocular coloboma, congenital heart defects, atresia of the choanae, retarded growth and development, genital hypoplasia, and ear anomalies including deafness. The cause of CHARGE remains unknown; however, there is considerable evidence of an underlying genetic basis, as discussed by Tellier et al. [1996: Clin Genet 50:548-550; 1998: Am J Med Genet 76:402-409] and by Martin et al. [2001: Am J Med Genet 99:115-119]. Based on the ocular, cardiac, and craniofacial expression pattern of Pitx2, a homeodomain transcription factor, and the pleiotropic effects of loss of PITX2 function in both mouse and human, we hypothesized that PITX2 mutations may contribute to the multiple phenotypic anomalies present in CHARGE individuals. By direct sequencing of DNA from 29 individuals with CHARGE, we did not identify any mutations in PITX2. We did, however, identify two PITX2 sequence polymorphisms. Large deletions of PITX2 were excluded in most patients by heterozygosity in at least one of several polymorphic markers near the PITX2 locus. Together, these data indicate that PITX2 mutations are unlikely to be a major contributing cause of the multiple anomalies present in individuals with CHARGE. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124729     DOI: 10.1002/ajmg.10473

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  Absent semicircular canals in CHARGE syndrome: radiologic spectrum of findings.

Authors:  A K Morimoto; R H Wiggins; P A Hudgins; G L Hedlund; B Hamilton; S K Mukherji; S A Telian; H R Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

2.  Epigenetic Developmental Disorders: CHARGE syndrome, a case study.

Authors:  Donna M Martin
Journal:  Curr Genet Med Rep       Date:  2015-03

3.  Fibroblast growth factor 9 (FGF9)-pituitary homeobox 2 (PITX2) pathway mediates transforming growth factor β (TGFβ) signaling to regulate cell proliferation in palatal mesenchyme during mouse palatogenesis.

Authors:  Jun-ichi Iwata; Lily Tung; Mark Urata; Joseph G Hacia; Richard Pelikan; Akiko Suzuki; Liza Ramenzoni; Obaid Chaudhry; Carolina Parada; Pedro A Sanchez-Lara; Yang Chai
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

Review 4.  CHARGE syndrome.

Authors:  Kim D Blake; Chitra Prasad
Journal:  Orphanet J Rare Dis       Date:  2006-09-07       Impact factor: 4.123

5.  SNP genotyping to screen for a common deletion in CHARGE syndrome.

Authors:  Seema R Lalani; Arsalan M Safiullah; Susan D Fernbach; Michael Phillips; Carlos A Bacino; Laura M Molinari; Nancy L Glass; Jeffrey A Towbin; William J Craigen; John W Belmont
Journal:  BMC Med Genet       Date:  2005-02-14       Impact factor: 2.103

6.  Mutational analysis of the PITX2 coding region revealed no common cause for transposition of the great arteries (dTGA).

Authors:  Nadja Muncke; Beate Niesler; Ralph Roeth; Karin Schön; Heinz-Juergen Rüdiger; Elizabeth Goldmuntz; Judith Goodship; Gudrun Rappold
Journal:  BMC Med Genet       Date:  2005-05-12       Impact factor: 2.103

Review 7.  Multiple Roles of Pitx2 in Cardiac Development and Disease.

Authors:  Diego Franco; David Sedmera; Estefanía Lozano-Velasco
Journal:  J Cardiovasc Dev Dis       Date:  2017-10-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.